Investor Presentation First Nine Months of 2022 slide image

Investor Presentation First Nine Months of 2022

19 Investor presentation First nine months of 2022 Appendix Novo Nordisk corporate strategy Diabetes care GLP-1 Insulin Obesity care 20 32 42 49 58 Rare disease 77 Other serious chronic diseases 89 Regional information 107 Financials 141 Sustainability 151
View entire presentation